What did the study from the Affiliated Cancer Hospital of Xiangya School of Medicine find?

The study found that patients receiving immunochemotherapy before 3:00 PM for extensive-stage small cell lung cancer had significantly longer progression-free and overall survival.

How does chronotherapy relate to cancer treatment timing?

Chronotherapy suggests that the body's natural daily rhythms affect how the immune system works and how drugs are processed, potentially making treatments more effective at certain times of day.

Should patients change their cancer treatment appointment times based on this study?

Experts advise that patients should not delay treatment or panic about appointment times, but the findings suggest exploring earlier infusion times if scheduling allows.

Home / Health / Cancer Treatment Timing Matters: Early Doses Boost Survival

Cancer Treatment Timing Matters: Early Doses Boost Survival

23 Dec

•

Summary

Treating lung cancer earlier in the day showed significantly greater patient benefit.
Patients receiving treatment before 3:00 PM had longer survival outcomes.
Chronotherapy suggests body rhythms impact immune function and drug effectiveness.

Cancer Treatment Timing Matters: Early Doses Boost Survival

New research indicates that the time of day patients receive cancer treatments could critically impact their outcomes. A study published in Cancer found that early-day immunochemotherapy for extensive-stage small cell lung cancer (ES-SCLC) yielded significantly greater benefits compared to afternoon treatments. Patients treated before 3:00 PM experienced substantially longer progression-free survival and overall survival.

The findings support the concept of chronotherapy, which posits that the body's circadian rhythms influence immune system function and drug metabolism. This suggests that cancer treatments might be more effective at specific times, as immune activity and how the body processes medication fluctuate over a 24-hour period. Researchers noted that earlier administration was associated with a notably lower risk of cancer progression and death.